Lactose India Ltd vs Parmax Pharma Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 04, 2026

Key Highlights

The Latest Trading Price of Lactose (India) Ltd is ₹ 113.05 as of 04 May 10:50 . The P/E Ratio of Lactose (India) Ltd changed from 30.7 on March 2022 to 21.6 on March 2025 . This represents a CAGR of -8.41% over 4 yearsThe P/E Ratio of Parmax Pharma Ltd changed from 21 on March 2021 to 0 on March 2025 . This represents a CAGR of -100.00% over 5 years The Market Cap of Lactose (India) Ltd changed from ₹ 30.54 crore on March 2021 to ₹ 111.66 crore on March 2025 . This represents a CAGR of 29.60% over 5 yearsThe Market Cap of Parmax Pharma Ltd changed from ₹ 13.28 crore on March 2021 to ₹ 15.8 crore on March 2025 . This represents a CAGR of 3.54% over 5 years The revenue of Lactose (India) Ltd for the Dec '25 is ₹ 37.4 crore as compare to the Sep '25 revenue of ₹ 41.55 crore. This represent the decline of -9.99% The revenue of Parmax Pharma Ltd for the Dec '25 is ₹ 4.33 crore as compare to the Sep '25 revenue of ₹ 2.54 crore. This represent the growth of 70.47% The ebitda of Lactose (India) Ltd for the Dec '25 is ₹ 3.7 crore as compare to the Sep '25 ebitda of ₹ 5.63 crore. This represent the decline of -34.28% The ebitda of Parmax Pharma Ltd for the Dec '25 is ₹ -0.19 crore as compare to the Sep '25 ebitda of ₹ -1.58 crore. This represent the decline of -87.97% The net profit of Lactose (India) Ltd changed from ₹ 2.27 crore to ₹ 0.53 crore over 7 quarters. This represents a CAGR of -56.45% The net profit of Parmax Pharma Ltd changed from ₹ 0.01 crore to ₹ -0.73 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Lactose (India) Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Parmax Pharma Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Lactose (India) Ltd

Lactose (India) Limited was incorporated on March 1991 as a Public Limited Company in Vadodara district of Gujarat.
Company engages in the manufacturing and trading of pharmaceutical products.
It edible and pharmaceutical grade lactose, as an ingredient used in pharmaceutical products, as well as in dairy, food, confectionery, and beverage industries.
It also manufactures dairy whitener, dairy calcium, whey powder, casein, caseinate, butter, and ghee.
Further, it engage in the contract manufacture of pharmaceutical products. The company is having their manufacturing facilities located at Vadodara in Gujarat.

About Parmax Pharma Ltd

Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara.
The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
The Company then discontinued their business activities for few years due to various reasons.
Starting from their journey as a bulk drug manufacturer and speciality chemicals in 1994; the Company had set up a plant to manufacture and market bulk drugs like amoxycillin tri-hydrate, ampicillin tri-hydrate, cephalexin mono hydrate and nalidixic acid, at Hadamtala, Gujarat, with an installed capacity of 96 TPA.

FAQs for the comparison of Lactose (India) Ltd and Parmax Pharma Ltd

Which company has a larger market capitalization, Lactose (India) Ltd or Parmax Pharma Ltd?

Market cap of Lactose (India) Ltd is 142 Cr while Market cap of Parmax Pharma Ltd is 11 Cr

What are the key factors driving the stock performance of Lactose (India) Ltd and Parmax Pharma Ltd?

The stock performance of Lactose (India) Ltd and Parmax Pharma Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Lactose (India) Ltd and Parmax Pharma Ltd?

As of May 4, 2026, the Lactose (India) Ltd stock price is INR ₹113.07. On the other hand, Parmax Pharma Ltd stock price is INR ₹30.02.

How do dividend payouts of Lactose (India) Ltd and Parmax Pharma Ltd compare?

To compare the dividend payouts of Lactose (India) Ltd and Parmax Pharma Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.